23andMe’s position on genomic diversity, international expansion
23andMe President Andy Page discusses the company's international expansion strategy - and interest in increasing the diversity of its genomics database.
23andMe President Andy Page discusses the company's international expansion strategy - and interest in increasing the diversity of its genomics database.
23andMe keeps moving forward with a massive round of fundraising.
Small practices play a critical role in healthcare delivery, but they cannot continue to absorb ever-increasing administrative demands without consequences.